Literature DB >> 20025529

Double-edged genetic swords and immunity: lesson from CCR5 and beyond.

Sunil K Ahuja, Weijing He.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20025529      PMCID： PMC3728730          DOI： 10.1086/649427

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  43 in total

1.  Cloning and functional expression of CC CKR5, a human monocyte CC chemokine receptor selective for MIP-1(alpha), MIP-1(beta), and RANTES.

Authors:  C Combadiere; S K Ahuja; H L Tiffany; P M Murphy
Journal:  J Leukoc Biol       Date:  1996-07       Impact factor: 4.962

Review 2.  CCR5: no longer a "good for nothing" gene--chemokine control of West Nile virus infection.

Authors:  Jean K Lim; William G Glass; David H McDermott; Philip M Murphy
Journal:  Trends Immunol       Date:  2006-06-05       Impact factor: 16.687

3.  Defects in the generation of IFN-gamma are overcome to control infection with Leishmania donovani in CC chemokine receptor (CCR) 5-, macrophage inflammatory protein-1 alpha-, or CCR2-deficient mice.

Authors:  N Sato; W A Kuziel; P C Melby; R L Reddick; V Kostecki; W Zhao; N Maeda; S K Ahuja; S S Ahuja
Journal:  J Immunol       Date:  1999-11-15       Impact factor: 5.422

4.  CCR5 expression and duration of high risk sexual activity among HIV-seronegative men who have sex with men.

Authors:  Susan M Thomas; Doris B Tse; D Scott Ketner; Gemma Rochford; Daniel A Meyer; David D Zade; Perry N Halkitis; Arthur Nádas; William Borkowsky; Michael Marmor
Journal:  AIDS       Date:  2006-09-11       Impact factor: 4.177

5.  Multiple active states and oligomerization of CCR5 revealed by functional properties of monoclonal antibodies.

Authors:  Cédric Blanpain; Jean-Marie Vanderwinden; Josef Cihak; Valérie Wittamer; Emmanuel Le Poul; Hassan Issafras; Manfred Stangassinger; Gilbert Vassart; Stefano Marullo; Detlef Schlndorff; Marc Parmentier; Matthias Mack
Journal:  Mol Biol Cell       Date:  2002-02       Impact factor: 4.138

6.  Effects of CCR5 and CD4 cell surface concentrations on infections by macrophagetropic isolates of human immunodeficiency virus type 1.

Authors:  E J Platt; K Wehrly; S E Kuhmann; B Chesebro; D Kabat
Journal:  J Virol       Date:  1998-04       Impact factor: 5.103

7.  CCL3L1 and CCR5 influence cell-mediated immunity and affect HIV-AIDS pathogenesis via viral entry-independent mechanisms.

Authors:  Matthew J Dolan; Hemant Kulkarni; Jose F Camargo; Weijing He; Alison Smith; Juan-Manuel Anaya; Toshiyuki Miura; Frederick M Hecht; Manju Mamtani; Florencia Pereyra; Vincent Marconi; Andrea Mangano; Luisa Sen; Rosa Bologna; Robert A Clark; Stephanie A Anderson; Judith Delmar; Robert J O'Connell; Andrew Lloyd; Jeffrey Martin; Seema S Ahuja; Brian K Agan; Bruce D Walker; Steven G Deeks; Sunil K Ahuja
Journal:  Nat Immunol       Date:  2007-10-21       Impact factor: 25.606

8.  The Duffy-null state is associated with a survival advantage in leukopenic HIV-infected persons of African ancestry.

Authors:  Hemant Kulkarni; Vincent C Marconi; Weijing He; Michael L Landrum; Jason F Okulicz; Judith Delmar; Dickran Kazandjian; John Castiblanco; Seema S Ahuja; Edwina J Wright; Robin A Weiss; Robert A Clark; Matthew J Dolan; Sunil K Ahuja
Journal:  Blood       Date:  2009-07-20       Impact factor: 22.113

9.  Duffy antigen receptor for chemokines mediates trans-infection of HIV-1 from red blood cells to target cells and affects HIV-AIDS susceptibility.

Authors:  Weijing He; Stuart Neil; Hemant Kulkarni; Edward Wright; Brian K Agan; Vincent C Marconi; Matthew J Dolan; Robin A Weiss; Sunil K Ahuja
Journal:  Cell Host Microbe       Date:  2008-07-17       Impact factor: 21.023

10.  Duffy antigen modifies the chemokine response in human endotoxemia.

Authors:  Florian B Mayr; Alexander O Spiel; Judith M Leitner; Christa Firbas; Tuende Kliegel; Petra Jilma-Stohlawetz; Hartmut Derendorf; Bernd Jilma
Journal:  Crit Care Med       Date:  2008-01       Impact factor: 7.598
View more
  5 in total

1.  West nile virus.

Authors:  Georg Pauli; Ursula Bauerfeind; Johannes Blümel; Reinhard Burger; Christian Drosten; Albrecht Gröner; Lutz Gürtler; Margarethe Heiden; Martin Hildebrandt; Bernd Jansen; Thomas Montag-Lessing; Ruth Offergeld; Rainer Seitz; Uwe Schlenkrich; Volkmar Schottstedt; Johanna Strobel; Hannelore Willkommen
Journal:  Transfus Med Hemother       Date:  2013-07-04       Impact factor: 3.747

2.  Ten questions for evolutionary studies of disease vulnerability.

Authors:  Randolph M Nesse
Journal:  Evol Appl       Date:  2011-01-17       Impact factor: 5.183

Review 3.  CCR5 as a Coreceptor for Human Immunodeficiency Virus and Simian Immunodeficiency Viruses: A Prototypic Love-Hate Affair.

Authors:  Anna J Jasinska; Ivona Pandrea; Cristian Apetrei
Journal:  Front Immunol       Date:  2022-01-27       Impact factor: 7.561

4.  Duffy-null-associated low neutrophil counts influence HIV-1 susceptibility in high-risk South African black women.

Authors:  Veron Ramsuran; Hemant Kulkarni; Weijing He; Koleka Mlisana; Edwina J Wright; Lise Werner; John Castiblanco; Rahul Dhanda; Tuan Le; Matthew J Dolan; Weihua Guan; Robin A Weiss; Robert A Clark; Salim S Abdool Karim; Sunil K Ahuja; Thumbi Ndung'u
Journal:  Clin Infect Dis       Date:  2011-05       Impact factor: 9.079

5.  COVID-19 outcomes and the human genome.

Authors:  Michael F Murray; Eimear E Kenny; Marylyn D Ritchie; Daniel J Rader; Allen E Bale; Monica A Giovanni; Noura S Abul-Husn
Journal:  Genet Med       Date:  2020-05-12       Impact factor: 8.822
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.